Vaishali Pharma Clarifies Preferential Allotment Consideration Following Share Valuation Adjustment

Vaishali Pharma Clarifies Preferential Allotment Consideration Following Share Valuation Adjustment​

Vaishali Pharma Limited has confirmed a material adjustment to the consideration for a preferential allotment of equity shares set to Kesar Pharma Limited (KPL), ensuring alignment with the valuation determined by a Registered Valuer. The transaction involves the issuance of up to 61,23,000 equity shares of Vaishali Pharma on a preferential basis to KPL, executed through a swap of KPL shares.

The company had previously received members' approval for this allotment via a special resolution passed through postal ballot on March 15, 2026. This initial approval was based on the acquisition of 21,52,575 equity shares of KPL at a value of Rs. 56.89 per Equity Share.

A subsequent review involving a Registered Valuer determined that the value of KPL's equity shares stood at Rs. 56.79 per equity share, resulting in a difference of Rs. 0.10 per equity share compared to the previously used valuation.

To fully address this difference and ensure the transaction consideration adheres strictly to the Registered Valuer’s report, Vaishali Pharma has confirmed that the aggregate differential amount of Rs. 2,15,258 will be received in cash from Kesar Pharma Limited. This amount corresponds to Rs. 0.10 per share across the 21,52,575 equity shares of KPL.

The company stated that this adjustment ensures the transaction is undertaken in accordance with the valuation report and applicable requirements.

VAISHALI Stock Price Movement​

Vaishali Pharma Limited shares surged today, settling at ₹7.67 after rising 3.62% in post-market trading. The equity saw a volume of 191,731 shares as it closed, reflecting strong performance throughout the day.